GEN Exclusives

More »

GEN News Highlights

More »
Jan 29, 2007

Sanaria Awarded Grant to Fund Work on Malaria Vaccine

  • Sanaria received two multiyear SBIR grants from the NIAID to enhance the development of its whole parasite malaria vaccine.

    The phase II grant is to establish multiple strains of the parasite that can be used to assess the effectiveness of Sanaria's malaria vaccine. The phase I grant is to develop additional methods for preserving Sanaria's malaria vaccine.
    The total first-year award for both grants is $1.21 million. Subject to satisfactory progress by Sanaria, continued funding in the second and third year will bring the total to $3.47 million.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?